Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
International Biotechnology TrustLSE:IBT +0.46%36 Pretax Margin % is 99.64% as of Feb. 2026, which is 2% above its 10-year median of 97.93. GuruFocus rates LSE:IBT with a GF Score™ of 36/100. The stock has 4 warning signs investors should review. Among 942 Biotechnology companies, International Biotechnology Trust ranks better than 97.88% on this metric.
The historical rank and industry rank for International Biotechnology Trust's Pretax Margin % or its related term are showing as below:
LSE:IBT'
s Pretax Margin % Range Over the Past 10 Years
Min: 81.65 Med: 97.93 Max: 652.57
Current: 99.01
LSE:IBT's Pretax Margin % is ranked better than 97.88% of 942
companies
in the Biotechnology industry
Industry Median: -89.895
vs LSE:IBT: 99.01
International Biotechnology Trust (LSE:IBT) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
International Biotechnology Trust Pretax Margin % Related Terms
International Biotechnology Trust Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
International Biotechnology Trust Pretax Margin % Chart
LSE:IBT vs VRTX, REGN, RVMD: Pretax Margin % Comparison
For the Biotechnology subindustry, International Biotechnology Trust's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
International Biotechnology Trust Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, International Biotechnology Trust's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where International Biotechnology Trust's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
International Biotechnology Trust (LSE:IBT) has a Pretax Margin % of 99.64% as of Feb. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on International Biotechnology Trust and its competitors. This is near median its historical median of 97.93. Over the past decade, International Biotechnology Trust's Pretax Margin % has ranged from 81.65 to 652.57. According to the industry distribution chart, International Biotechnology Trust ranks #20 out of 942 companies in the Biotechnology industry, placing it in the top 2.1%.
Is International Biotechnology Trust's Pretax Margin % too high?
International Biotechnology Trust's current Pretax Margin % of 99.64% is near median its 10-year median of 97.93. Over the past 10 years, this metric has ranged from a low of 81.65 to a high of 652.57. Based on the distribution chart, International Biotechnology Trust ranks #20 out of 942 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, International Biotechnology Trust has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does International Biotechnology Trust's Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, International Biotechnology Trust ranks #20 out of 942 companies for Pretax Margin %. This places International Biotechnology Trust in the top 2% of its industry — outperforming the majority of peers. Historically, International Biotechnology Trust's own Pretax Margin % has ranged from 81.65 to 652.57 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on International Biotechnology Trust and its competitors. International Biotechnology Trust's current Pretax Margin % is 99.64%, which is near median its own 10-year median of 97.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is International Biotechnology Trust stock overvalued right now?
International Biotechnology Trust (LSE:IBT) has a current Pretax Margin % of 99.64%. The current Pretax Margin % is 99.64%, which is near median its 10-year median of 97.93. International Biotechnology Trust's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For International Biotechnology Trust (LSE:IBT), the current Pretax Margin % is 99.64% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
International Biotechnology Trust Business Description
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments ,and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.
36GF Score
Get the complete analysis for LSE:IBT
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:IBT has been successfully added to your 
